0001824920false00018249202026-11-032026-11-03

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 03, 2026

 

 

IonQ, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39694

85-2992192

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

4505 Campus Drive

 

College Park, Maryland

 

20740

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 301 298-7997

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common stock, par value $0.0001 per share

 

IONQ

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 2.01 Completion of Acquisition or Disposition of Assets.

On November 3, 2026, IonQ, Inc. (the “Company”) completed its previously announced acquisition (the “Acquisition”) of all of the issued and outstanding shares of common stock of Elisity, Inc., a Delaware corporation (“Elisity”), pursuant to the terms of the Agreement and Plan of Merger, dated as of October 9, 2026, by and among the Company, Elisity, Espresso Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company, and Fortis Advisors LLC, solely in its capacity as the representative of the securityholders (the “Holder Representative”). The consideration (the “Closing Consideration”) delivered in connection with the closing of the Acquisition consists of 32,233,274 shares of the Company’s common stock, par value $0.0001 per share (each, a “Share”). In addition to the Closing Consideration, Elisity’s securityholders will be eligible to receive up to 4,265,934 Shares in earn-out consideration, depending on the achievement of financial metrics through January 2028, which, together with the Closing Consideration, constitutes the merger consideration of up to 36,499,208 Shares (the “Merger Consideration”).

In connection with the closing of the Acquisition and the issuance of the Merger Consideration, the Company and the Holder Representative entered into a Registration Rights Agreement, dated as of November 3, 2026 (the “Registration Rights Agreement”), pursuant to which recipients of the Closing Consideration have certain registration rights with respect thereto.

The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Registration Rights Agreement, a copy of which is filed herewith as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

Item 2.02 Results of Operations and Financial Condition.

On November 5, 2026, the Company issued a press release announcing its financial results for the second quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities.

The information set forth under Item 2.01 of this Current Report on Form 8-K related to the Closing Consideration is incorporated herein by reference. The Shares were issued pursuant to one or more exemptions from registration under the Securities Act of 1933, as amended (the “Securities Act”), including those provided by Section 4(a)(2) of the Securities Act and Regulation D and Regulation S promulgated under the Securities Act.

Item 7.01 Regulation FD Disclosure.

On November 4, 2026, the Company issued a press release announcing the closing of the Acquisition. A copy of the press release has been furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.

The information provided pursuant to Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company’s filings under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit
No.

Description

10.1

Registration Rights Agreement, dated as of November 3, 2026, by and between IonQ, Inc. and the Holder Representative named therein.

99.1

Press Release, dated November 5, 2026.

99.2

Press Release announcing the closing of the Acquisition, dated November 4, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

IonQ, Inc.

 

 

 

 

Date:

November 5, 2026

By:

/s/ Paul T. Dacier

 

 

 

Paul T. Dacier
Chief Legal Officer and Corporate Secretary

 


Exhibit 10.1

REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 3, 2026 by and between IonQ, Inc., a Delaware corporation (“Parent”), and Fortis Advisors LLC, a Delaware limited liability company (the “Holder Representative”), solely in its capacity as the agent, representative and attorney-in-fact for and on behalf of the Holders under this Agreement who are being issued shares of Parent Common Stock pursuant to the Merger Agreement (as defined below). Notwithstanding anything in this Agreement to the contrary, all duties of the Holders herein shall be personal to such Holders and are not the responsibility of the Holder Representative, and the Holder Representative shall have no duties hereunder that are not expressly given to it by this Agreement.

RECITALS

WHEREAS, pursuant to that certain Agreement and Plan of Merger, dated as of October 9, 2026 (as the same may be amended from time to time, the “Merger Agreement”), by and among Parent, Espresso Acquisition Sub, Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent (“Merger Sub”), Elisity, Inc., a Delaware corporation (the “Company”), and the Holder Representative, Merger Sub will be merged with and into the Company, the separate corporate existence of Merger Sub will cease, and the Company will continue as the surviving corporation, on the terms and subject to the conditions set forth therein (the “Merger”).

WHEREAS, as a condition and inducement to the willingness of the Company to consummate the Merger and the other transactions contemplated by the Merger Agreement, the Company has requested that Parent enter into this Agreement.

WHEREAS, in order to induce the Company and the Securityholders to consummate the Merger and the other transactions contemplated by the Merger Agreement, Parent is willing to enter into this Agreement.

NOW, THEREFORE, in consideration of the covenants and other agreements of each party contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, the parties hereto hereby agree as follows:

1.
Definitions. All capitalized terms that are used but not defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement. For all purposes of and under this Agreement, the following capitalized terms shall have the respective meanings below:
(a)
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
(b)
“Form S‑3” means a registration statement on Form S‑3 promulgated by the SEC under the Securities Act, as such form is in effect on the date hereof, or any successor or replacement form of registration statement promulgated by the SEC under the Securities Act from and after the date hereof, in any such case which similarly permits inclusion or incorporation of substantial information by reference to other documents filed by Parent with the SEC.

1

 


 

(c)
“Holder” means a Securityholder to whom shares of Parent Common Stock are issued pursuant to the Merger Agreement or a transferee to whom registration rights granted under this Agreement are assigned pursuant to Section 6 hereof.
(d)
“Registrable Securities” means, for each Holder, (i) the number of shares of Parent Common Stock issued to such Holder pursuant to the Merger Agreement, which, for the avoidance of doubt, shall include shares of Parent Common Stock issued as the Earnout Amount (the “Earnout Shares”), and (ii) any Parent Common Stock or other equity securities or interests issued as a dividend or other distribution with respect to or in exchange for or in replacement of the stock referenced in clause (i) above, and for all Holders, the sum of the Registrable Securities held by them as a group; provided, however, that shares of Parent Common Stock, including Earnout Shares, held by a particular Holder shall cease to be Registrable Securities (x) after a Registration Statement with respect to the sale of such securities has been declared effective under the Securities Act and such securities have been disposed of in accordance with such Registration Statement and with Section 2 hereof or (y) at such time as such Holder is eligible to sell such securities without registration and, under Rule 144 of the Securities Act, without any limitation as to volume, manner of sale limitations or current public information requirements thereunder.
(e)
“Securities Act” means the Securities Act of 1933, as amended.
(f)
“SEC” means the United States Securities and Exchange Commission.
2.
Registration of Offers and Sales of Registrable Securities.
(a)
Subject to applicable Law, as promptly as reasonably practicable and in any event within ten (10) business days after the Closing (and with respect to the Earnout Shares, ten (10) business days after issuance), Parent shall file an automatic shelf registration statement on Form S‑3 (or any similar provisions then in force) promulgated under the Securities Act to be effective immediately upon filing (or, solely if Parent is not then eligible to file an automatic shelf registration statement on Form S‑3, a registration statement on Form S-3, or if Form S-3 is not available for purposes of registering the resale of the shares of Parent Common Stock to be issued pursuant to the Merger Agreement, then on another appropriate form) (the “Registration Statement”) registering the resale of all Registrable Securities; provided that, Parent’s obligation to include the Registrable Securities of any Holder in a Registration Statement shall be expressly conditioned upon Parent’s prior receipt of all information and materials regarding such Holder as specified in Section 7 and the taking of all action reasonably required to be taken by such Holder. In lieu of filing such Registration Statement, Parent may, in accordance with Section 10 hereof and within ten (10) business days after the Closing (or, with respect to the Earnout Shares, issuance), file a prospectus supplement (covering the resale of all Registrable Securities) which supplements a prospectus contained in an effective registration statement on Form S-3 which has already been filed by Parent.
(b)
Notwithstanding Section 2(a) or Section 2(c): (i)(A) Parent shall not be required to file a Registration Statement contemplated by Section 2(a) during any trading “blackout” period under Parent’s securities trading policies, (B) Parent shall not be required to file a Registration Statement contemplated by Section 2(a) if Parent, in its reasonable good faith judgment, has determined that the offer and sale or other disposition of Registrable Securities

2

 


 

pursuant to a Registration Statement would require public disclosure by Parent of material nonpublic information that Parent is not otherwise obligated to disclose or that is not reasonably available, and (C) Parent shall not be deemed to have breached its obligations hereunder or under the Merger Agreement if Parent shall fail to fulfill its obligations under Section 2(a) at a time when sales of Parent Common Stock have been suspended globally under Parent’s then effective registration statements or during times when new registration statements are not permitted to be filed under SEC rules, provided, that if Parent delays the filing of a Registration Statement pursuant to this Section 2(b), it shall use commercially reasonable efforts to file such Registration Statement as soon as reasonably practicable following the lapsing or expiration of the circumstances that led Parent to delay such filing; and (ii) in the event that Parent has not received the consent of its independent registered public accounting firm or other required consents from auditors to include such firm’s audit report in a Registration Statement, then Parent shall not be required to file a Registration Statement contemplated by Section 2(a) until Parent shall have received such consents, provided, that Parent has used commercially reasonable efforts to obtain such consents.
(c)
Parent shall use its commercially reasonable efforts to: (i) to the extent that a Registration Statement is not automatically effective upon filing with the SEC, cause such Registration Statement to be declared effective as promptly as reasonably practicable after the filing thereof with the SEC (and shall request acceleration of effectiveness of such Registration Statement by the SEC no later than the end of the second (2nd) Business Day after receiving notice from the SEC that it will not review such Registration Statement or that any SEC comments have been resolved to the satisfaction of the SEC), and keep such Registration Statement effective until the earliest to occur of (A) the date on which all Registrable Securities included in such Registration Statement have been sold, (B) such time as each Holder is eligible to sell all Registrable Securities under Rule 144 of the Securities Act, without any limitation as to volume, manner of sale, or current public information requirements under applicable Law (and not limitations as to volume pursuant to Holder’s Stock Issuance Agreement), or (C) the 180-day anniversary of the date on which such Registration Statement first becomes effective (or, if Parent files a prospectus supplement in lieu thereof pursuant to Section 2(a), the date on which such prospectus supplement is filed with the SEC) (ii) prepare and file with the SEC such amendments to such Registration Statement and amendments or supplements to the prospectus used in connection therewith as may be necessary to comply with the provisions of the Securities Act with respect to the sale or other disposition of all Registrable Securities included in such Registration Statement; (iii) furnish to each Holder such number of copies of any prospectus (including any preliminary prospectus and any amended or supplemented prospectus) in conformity with the requirements of the Securities Act as each Holder may reasonably request in order to effect the offering and sale of the Registrable Securities to be offered and sold by such Holder thereunder, but only while Parent shall be required under the provisions hereof to cause such Registration Statement to remain effective; (iv) register or qualify the Registrable Securities covered by such Registration Statement under the securities or blue sky laws of such jurisdictions as each Holder shall reasonably request, provided, however, that Parent shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such jurisdiction where it has not been qualified or is not otherwise subject to a general consent for service of process; and (v) notify each Holder, promptly after it shall receive notice thereof, of the date and time such Registration Statement and each post-effective amendment thereto shall have become or been declared effective, or an amendment or supplement

3

 


 

to any prospectus forming a part of such Registration Statement shall have been filed with the SEC.
3.
Suspension of Offers and Sales of Registrable Securities under Registration Statement. At any time from and after the effective date of a Registration Statement, Parent may restrict offers and sales or other dispositions of Registrable Securities under such Registration Statement, and a Holder will not be able to offer or sell or otherwise dispose of Registrable Securities thereunder, by delivering a written notice (a “Suspension Notice”) to all Holders of Registrable Securities (such delivery shall be made to each such Holder in accordance with Section 13) stating that a delay in the offer and sale or other disposition of Registrable Securities is necessary because Parent, in its reasonable good faith judgment, has determined that the offer and sale or other disposition of Registrable Securities would require public disclosure by Parent of material nonpublic information concerning Parent, the disclosure of which at the time is not, in the good faith opinion of Parent, in the best interests of Parent; provided, however, Parent may not suspend offers and sales or other dispositions of Registrable Securities pursuant to this Section 3 for more than sixty (60) days in the aggregate in any one (1) year period. Promptly following the cessation or discontinuance of the facts and circumstances forming the basis for any Suspension Notice, Parent shall use its commercially reasonable efforts to amend such Registration Statement and/or amend or supplement the related prospectus included therein to the extent necessary, and take all other actions reasonably necessary, to allow the offer and sale or other disposition of Registrable Securities to recommence as promptly as possible, and promptly notify all Holders of Registrable Securities in writing when such offers and sales or other dispositions of Registrable Securities under such Registration Statement may recommence. Upon receipt of a Suspension Notice, Holders shall immediately suspend their use of such Registration Statement and any prospectus included therein or forming a part thereof to offer and sell or otherwise dispose of Registrable Securities, and shall not offer or sell or otherwise dispose of Registrable Securities under such Registration Statement or any prospectus included therein or forming a part thereof until receipt of a notice from Parent pursuant to the preceding sentence that offers and sales or other dispositions of Registrable Securities may recommence. Holders shall keep the fact that Parent has delivered a Suspension Notice confidential. Parent shall not be permitted to register under the Securities Act any equity securities of Parent for its own account or held by other Persons during any such suspension period. Parent shall not, without the prior written consent of a Holder, disclose to such Holder any material non-public information related to the Suspension Notice.
4.
Fees and Expenses. All of the out-of-pocket expenses incurred in connection with any registration of Registrable Securities pursuant to this Agreement, including all SEC fees, blue sky registration and filing fees, New York Stock Exchange notices and filing fees, printing fees and expenses, transfer agents’ and registrars’ fees and expenses and all fees and expenses of Parent’s outside counsel and independent accountants shall be paid by Parent. Notwithstanding anything herein to the contrary, Parent shall not be responsible for selling expenses of any Holder, including (i) underwriting discounts, (ii) selling commissions, (iii) fees, commissions and expenses of underwriters, brokers, dealer managers and similar securities industry professionals, (iv) stock transfer taxes applicable to the sale of Registrable Securities, and (v) fees and disbursements of legal counsel, financial advisors, accountants, and other professionals for any Holder, each of which shall be the responsibility of the Holders in proportion to the Registrable Securities owned by such Holders.

4

 


 

5.
Indemnification.
(a)
To the extent permitted by applicable Law, Parent shall indemnify and hold harmless each Holder, and each of its directors, officers, partners, members, managers and employees and other agents and representatives, and each person controlling such Holder within the meaning of Section 15 of the Securities Act (each, a “Holder Indemnified Party”), with respect to which registration, qualification or compliance has been effected pursuant to this Agreement, from and against all losses, claims, damages, costs, expenses, and liabilities (or actions in respect thereof), including any of the foregoing incurred in settlement of any litigation, commenced or threatened, arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in a Registration Statement, the prospectus forming a part thereof or included therein, any issuer free writing prospectus (as defined in Rule 433 under the Securities Act), and any amendment or supplement thereto, incident to any such registration, qualification or compliance, or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or any violation by Parent of any rule or regulation promulgated under the Securities Act, Exchange Act or state securities laws applicable to Parent in connection with any such registration, qualification or compliance, and Parent shall reimburse each Holder Indemnified Party for any legal and any other fees or expenses reasonably incurred by them in connection with investigating, preparing or defending any lawsuit, claim or action relating thereto; provided, however, that Parent shall not be required to indemnify, hold harmless, or otherwise be liable to any Holder Indemnified Party, in each case, to the extent, but only to the extent, that any such loss, damage, liability or expense arises out of, or is based on (i) any untrue statement or omission or alleged untrue statement or omission, made in reliance upon and in conformity with written information furnished by or on behalf of such Holder Indemnified Party to Parent specifically for use therein, or (ii) the failure of such Holder Indemnified Party to comply with its covenants and agreements hereunder.
(b)
To the extent permitted by applicable Law, if Registrable Securities held by a Holder are included in the securities as to which such registration, qualification or compliance is being effected, such Holder shall, severally and not jointly, indemnify and hold harmless Parent, each of its directors, officers, employees and other agents and representatives, each person controlling Parent within the meaning of Section 15 of the Securities Act, and Parent’s legal counsel and independent accountants (each a “Parent Indemnified Party”), from and against all losses, damages and liabilities (or actions in respect thereof) arising out of, or based on, any untrue statement (or alleged untrue statement) of a material fact contained in a Registration Statement, the prospectus forming a part thereof or included therein, and any amendment or supplement thereto, incident to any such registration, qualification or compliance, or any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or any violation by such Holder of any rule or regulation promulgated under the Securities Act, Exchange Act or state securities laws applicable to such Holder in connection with any such registration, qualification or compliance, and such Holder shall reimburse each Parent Indemnified Party for any legal or any other expenses reasonably incurred by them in connection with investigating or defending any such lawsuit, claim or action relating thereto, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering circular or other document in reliance upon and in conformity with written information furnished by such Holder to Parent specifically for use therein; provided, however,

5

 


 

that the total amount to be indemnified or contributed by any Holder under this Section 5 shall be limited to the net proceeds received by such Holder upon the sale of Registrable Securities pursuant to a Registration Statement, except in case of fraud or willful misconduct committed by each Holder.
(c)
Each party entitled to indemnification under this Section 5 (the “Indemnified Party”) shall give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has written notice of any lawsuit, claim or action as to which indemnity may be sought hereunder, and shall permit the Indemnifying Party to assume the defense of any such lawsuit, claim or action; provided, however, that counsel for the Indemnifying Party, who shall conduct the defense of such claim or litigation, shall be approved by the Indemnified Party (whose approval shall not be unreasonably withheld, delayed or conditioned), and the Indemnified Party may participate in such defense at such party’s expense (including by retaining its own counsel at its own expense), and, upon reasonable request, will be apprised of all progress in any proceeding the defense of which has been assumed by the Indemnifying Party to the extent permitted by applicable Law; provided, further that the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Agreement except to the extent, but only to the extent, that the Indemnifying Party’s ability to defend against such claim or litigation is materially and adversely impacted by the failure to give such notice. No Indemnifying Party, in the defense of any such lawsuit, claim or action shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to the Indemnified Party of a release from all liability in respect to such lawsuit, claim or action.
(d)
If the indemnification required by this Section 5 from the Indemnifying Party is unavailable to or insufficient to hold harmless an Indemnified Party in respect of any indemnifiable losses, claims, damages, liabilities, or expenses, then the Indemnifying Party shall contribute to the amount paid or payable by the Indemnified Party as a result of such losses, claims, damages, liabilities, or expenses in such proportion as is appropriate to reflect relative fault of the Indemnified Party and Indemnifying Parties, in connection with the actions which resulted in such losses, claims, damages, liabilities, or expenses, as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and the Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact, has been made by, or relates to information supplied by, such Indemnifying Party or Indemnified Parties, and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the losses, claims, damage, liabilities, and expenses referred to above shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with any investigation or proceeding. Parent and the Holders agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the prior provisions of this Section 5(d).
(e)
The obligations of Parent and each Holder under this Section 5 shall survive the permitted transfer of any Registrable Securities by any Holder, the completion of any offering and sale or other disposition of Registrable Securities in a Registration Statement filed with the

6

 


 

SEC pursuant to this Agreement, and the termination of this Agreement, until the expiration of any statute of limitations relating to the subject matter of this Section 5.
6.
Limitation on Assignment of Registration Rights. The rights of each Holder under this Agreement may not be assigned by a Holder to any other Person unless such a transfer of a portion or all of such Holder’s Registrable Securities is (a) if Holder is a natural person, pursuant to (i) a transfer of Registrable Securities by will or intestate succession or (ii) a trust or other estate planning entity created for the benefit of Holder or his or her family members for estate planning purposes, (b) if Holder is not a natural person, to its partners, members, stockholders or subsidiaries, or (c) with the prior written consent of Parent. Holder shall retain rights under this Agreement with respect to any Registrable Securities not transferred. Prior to a permitted transfer of rights under this Agreement, Holder must furnish Parent with written notice of the name and address of such transferee and the Registrable Securities with respect to which such registration rights are being assigned and a copy of a duly executed written instrument, in form and substance reasonably satisfactory to Parent, by which such transferee assumes all of the obligations and liabilities of its transferor hereunder and agrees itself to be bound hereby. No transfer of rights under this Agreement shall be permitted if, immediately following such transfer, the offer and sale or other disposition of Registrable Securities by the transferee is not restricted under the Securities Act.
7.
Information by Holder. Any Holder of Registrable Securities to be included in a Registration Statement shall furnish to Parent such information regarding such Holder, the Registrable Securities held by such Holder and the offer and sale or other distribution proposed by such Holder as may be required in connection with any registration, qualification or compliance contemplated by this Agreement, under applicable Law in order to permit Parent to comply with all applicable requirements of the Securities Act and the Exchange Act in connection with the registration of all Registrable Securities of such Holder under the Securities Act, and/or as Parent may reasonably request. Each Holder shall comply with the prospectus delivery requirements of the Securities Act in connection with any disposal of Registrable Securities under such Registration Statement by such Holder.
8.
Reporting. Subject to Section 2 of this Agreement, during the term of this Agreement, Parent shall use its commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of Parent under the Securities Act and the Exchange Act.
9.
Delay of Registration. No Holder shall have any right to take any action to restrain, enjoin, or otherwise delay any registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Agreement.
10.
Existing Registration Statements. Notwithstanding anything herein to the contrary and subject to applicable Law and regulation, Parent may satisfy any obligation hereunder to file a registration statement or to have a registration statement become effective by designating a registration statement that previously has been filed with the SEC or become effective, as the case may be, as the relevant registration statement for purposes of satisfying such obligation, and all references to any such obligation shall be construed accordingly; provided that such previously filed registration statement may be, and is, amended or, subject to applicable securities laws,

7

 


 

supplemented to add the number of Registrable Securities, and, to the extent necessary, to identify as selling stockholders the Holders pursuant to the terms of this Agreement. To the extent this Agreement refers to the filing or effectiveness of other Registration Statements, by or at a specified time and Parent has, in lieu of then filing such Registration Statements or having such Registration Statements become effective, designated a previously filed or effective registration statement as the relevant Registration Statement for such purposes, in accordance with the preceding sentence, such references shall be construed to refer to such designated Registration Statement, as amended or supplemented in the manner contemplated by the immediately preceding sentence.
11.
Rule 144 Requirements. With a view to making available to the Holders of Registrable Securities the benefits of Rule 144 and Rule 144A promulgated under the Securities Act and other rules and regulations of the SEC that may at any time permit a Holder to sell securities of Parent to the public without registration, Parent covenants that it will use its reasonable best efforts (a) to file in a timely manner all reports and other documents required, if any, to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted thereunder, (b) if it is not required to file such reports, make available information necessary to comply with Rule 144 and Rule 144A, if available with respect to resales of the Registrable Securities under the Securities Act, at all times, and (c) take such further action as any Holder or Holders of Registrable Securities may reasonably request, all to the extent required from time to time to enable such Holder to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 and Rule 144A promulgated under the Securities Act (if available with respect to resales of the Registrable Securities), as such rules may be amended from time to time, or (ii) any other rules or regulations now existing or hereafter adopted by the SEC.
12.
Trading Limitation. The number of shares of Parent Common Stock sold by each Holder under a Registration Statement or otherwise on any trading day shall not exceed the lesser of: (x) 10% of the average daily reported volume of trading in Parent Common Stock on all national securities exchanges and/or reported through the automated quotation system of a registered securities association during the five trading days preceding the date of such sale of Parent Common Stock by such Holder and (y) 10% of the Registrable Securities issued to such Holder; provided, that this restriction shall only apply to Holders who received Parent Common Stock with a value at the Closing of at least $1 million.
13.
Notices. Any notice or other communication required or permitted to be delivered to any party under this Agreement shall be made and given in compliance with the provisions of Section 10.1 of the Merger Agreement and, if to a Holder, to such Holder’s address (including email address) set forth in the Letter of Transmittal delivered by such Holder pursuant to the Merger Agreement.
14.
Amendment of this Agreement. Subject to the provisions of applicable Law, Parent and the Holder Representative may amend this Agreement at any time pursuant to an instrument in writing signed on behalf of each of them.
15.
Governing Law. This Agreement, and all actions, Claims, matters, proceedings or counterclaims (whether based on contract, tort, or otherwise) arising out of, relating to, or in connection with this Agreement or the actions of the parties hereto in the negotiation,

8

 


 

administration, performance and enforcement hereof or any Related Agreement (the “Relevant Matters”), shall be governed by and construed in accordance with the Laws of the State of Delaware, without giving effect to any choice or conflict of laws provision, rule or principle (whether of the State of Delaware or any other jurisdiction) that would result in the application of the laws of any other jurisdiction. Notwithstanding the foregoing, and for the avoidance of doubt, this Section 15 shall not apply to any Relevant Matter to the extent a Related Agreement selects a different governing Law, in which case, such governing Law provision in such Related Agreement shall control.
16.
Jurisdiction; Service of Process. The parties hereto irrevocably submit to the exclusive jurisdiction of the Delaware Court of Chancery or, in the event (but only in the event) that such court does not have subject matter jurisdiction over such suit, action or proceeding, of the United States District Court for the District of Delaware over any suit, action or proceeding arising out of or relating to this Agreement, the Related Agreements or the Transactions. To the fullest extent that they may effectively do so under applicable Law, the parties hereto irrevocably waive and agree not to assert, by way of motion, as a defense or otherwise, any claim that they are not subject to the jurisdiction of any such court, any objection that they may now or hereafter have to the laying of the venue of any such legal proceeding brought in any such court and any claim that any such legal proceeding brought in any such court has been brought in an inconvenient forum. Each party hereby irrevocably consents to the service of process of any of the aforementioned courts in any such legal proceeding by the mailing of copies thereof by registered or certified mail or by overnight courier service, postage prepaid, to its address set forth in Section 10.1 of the Merger Agreement, such service to become effective ten (10) days after such mailing.
17.
Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT, OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER RELEVANT MATTER.
18.
Entire Agreement. This Agreement, the Related Agreements, and the documents and instruments and other agreements among the parties hereto referenced herein constitute the entire agreement among the parties hereto with respect to the subject matter of this Agreement and supersede all prior agreements and understandings both written and oral, among the parties with respect to the subject matter of this Agreement, and are not intended to confer upon any other person any rights or remedies hereunder.
19.
Severability. In the event that any provision of this Agreement or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties hereto. The parties further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision.

9

 


 

20.
Successors and Assigns. Subject to the provisions of Section 6, the provisions of this Agreement shall inure to the benefit of, and shall be binding upon, the successors and permitted assigns of the parties hereto.
21.
Specific Performance and Other Remedies.
(a)
The parties to this Agreement agree that, in the event of any breach or threatened breach by Parent, any Holder or the Holder Representative of any covenant, obligation or other agreement set forth in this Agreement, (i) each party shall be entitled, without any proof of actual damages (and in addition to any other remedy that may be available to it), to an Order of specific performance or mandamus to enforce the observance and performance of such covenant, obligation or other agreement and an injunction preventing or restraining such breach or threatened breach, and (ii) no party hereto shall be required to provide or post any bond or other security or collateral in connection with any such Order or injunction or in connection with any related action or legal proceeding.
(b)
Any and all remedies herein expressly conferred herein upon a party hereto shall be deemed to be cumulative with, and not exclusive of, any other remedy conferred hereby, or by law or in equity upon such party, and the exercise by a party hereto of any one remedy will not preclude the exercise of any other remedy.
(c)
The Holders are express third-party beneficiaries of this Agreement, and each Holder shall have the right to enforce this Agreement as to Parent directly to the extent it may deem such enforcement necessary or advisable to protect such Holder’s rights or the rights of the Holders hereunder.
22.
Rules of Construction. The parties hereto have been represented by counsel during the negotiation, preparation and execution of this Agreement and, therefore, hereby waive, with respect to this Agreement, each Schedule and each Exhibit attached hereto, the application of any Law or rule of construction providing that ambiguities in an agreement or other document shall be construed against the party drafting such agreement or document.
23.
Counterparts. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party, it being understood that all parties need not sign the same counterpart. The exchange of a fully executed Agreement (in counterparts or otherwise) by electronic transmission in PDF format shall be sufficient to bind the parties to the terms and conditions of this Agreement.
24.
Termination. This Agreement shall terminate and cease to be of any force and effect upon the earliest of (i) termination of the Merger Agreement, (ii) at such time as each Holder is eligible to sell all Registrable Securities under Rule 144 of the Securities Act, without any limitation as to volume, manner of sale, or current public information requirements under applicable Law and no limitations as to volume set forth in Section 12 of this Agreement and (iii) one (1) year after the later of the Closing or the issuance of the Earnout Shares. For clarity, the obligations under Section 5, Section 11, and Sections 13 through this Section 24 will survive any termination of this Agreement.

10

 


 

[Remainder of Page Intentionally Left Blank]

11

 


 

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written.

 

 

PARENT:

IONQ, INC.

 

By: /s/ Tyler Rosenbaum

Name: Tyler Rosenbaum

Title: Authorized Signatory

[Signature Page to Registration Rights Agreement]

 


 

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written.

 

 

HOLDER REPRESENTATIVE:

 

FORTIS ADVISORS LLC

 

By: /s/ Ryan Simkin

Name: Ryan Simkin

Title: Managing Director

 

[Signature Page to Registration Rights Agreement]

 


Exhibit 99.1

IonQ Announces Record 3Q26 Revenues and Raises FY2026 Guidance to $505 - $515 Million as Backlog Grows to $1.2 Billion
Revenue, GAAP EPS and Adjusted EPS All Exceed Consensus Estimates*

●
Reported GAAP Revenue of $173.8 Million, Up 336% Year-over-Year, Marking the Sixth Consecutive Record Quarter
●
Raises Full Year Revenue Guidance to $505 to $515 Million and Expects 110% Year-Over-Year Growth in Quantum Computing
●
IonQ Platform Segment Revenue Up 127% to $90.3 Million on Global Tempo Quantum Computer Deployments
●
SkyWater Foundry Services Segment Revenue of $83.5 Million; Non-IonQ Quantum Customer Revenue Up More than 30% Year-over-Year as SkyWater Quantum Solutions is Launched
●
Only Trapped Ion Company Advanced to Stage C of the Defense Advanced Research Projects Agency’s Quantum Benchmarking Initiative, with a Potential Program Value of up to $300 Million
●
Superion 256 System Will Be the First On-Premise Quantum Computer at NVIDIA’s Accelerated Quantum Research Center
●
Extends Quantum Security Platform by Acquiring Elisity to Identify Vulnerabilities, Enforce Zero Trust and Provide Cryptographic Agility for Customers as they Prepare for the Quantum Era
●
Remains Best-Capitalized Pure-Play Quantum Company with $3.7 Billion in Cash, Cash Equivalents and Investments as of September 30, 2026 Pro-Forma for October 16, 2026 Equity Offering

*Adjusted EPS is a non-GAAP financial measure defined under “Non-GAAP Financial Measures,” below, and is reconciled to GAAP EPS, the closest comparable GAAP measure at the end of this release.

COLLEGE PARK, Md. – November 5, 2026 – IonQ (NYSE: IONQ), the world’s leading full-stack quantum platform and foundry, today announced financial results for the quarter ended September 30, 2026.

“I am pleased to report that IonQ delivered its sixth consecutive quarter of record results and the strongest quarter in our company’s history,” said Niccolo de Masi, Chairman and CEO. “Third quarter revenue of $173.8 million reflects increasing demand for our quantum technologies and the benefits of our vertically integrated quantum manufacturing capabilities through SkyWater.”

de Masi continued, “Recent developments have provided meaningful validation of our technology and commercial strategy. We are deeply proud that IonQ is the only trapped-ion company to advance to DARPA Stage C. This final stage of DARPA’s Quantum Benchmarking Initiative includes a potential program value of up to $300 million. In addition, NVIDIA will deploy a Superion 256 system as the first on-premise quantum computer at its Accelerated Quantum Research Center – connected directly to its AI supercomputing infrastructure. Both decisions underscore IonQ’s relentless focus on leading the industry with deployable quantum computers – built for data centers and designed to work with classical computing.”

de Masi concluded, “IonQ is building the quantum ecosystem as the first vertically integrated quantum technology company that spans computing, networking, sensing, and security. At SkyWater, we were pleased to welcome Qolab, founded by Nobel Prize winner John Martinis, as a new quantum customer. We also extended our multi-year collaboration with D-Wave and launched our OnRamp Foundry Initiative to accelerate quantum startups from laboratory prototype to commercial manufacturing.”

“One of our customers’ most urgent needs today is cybersecurity that protects them now and keeps them protected as post-quantum standards evolve. Our acquisition of Elisity extends our strategy to meet that need, adding Zero


Trust technology that is both a perfect complement and accelerant to our PQC and QKD solutions. We are focused on integrating and leveraging IonQ’s differentiated solutions to drive durable growth and long-term profitability.”

Third Quarter and Recent Commercial Highlights

IonQ Platform

●
$33 Million Multi-Product Contract with SDT to Deploy Superion 256 Quantum Computer and Quantum Memory Platform
●
$28 Million Contract through the DARPA It’s About Time Program to Deliver 25 Optical Atomic Clocks for Mission-Critical Applications, with $30 Million Option for 100 Additional Production Units
●
$25 Million Contract with Florida International University to Deploy Superion 256 Quantum Computer
●
$8.2 Million Contract with Congruity360 to Deploy IonQ’s PQC and QKD Solutions, Protecting Sensitive Enterprise Data for Clients across the U.S.
●
Awarded $7.5 Million Follow-On Funding from the Air Force Research Laboratory to Advance Full-Stack Quantum Networking
●
Signed Memorandum of Understanding with Northrop Grumman to Collaborate on Supply Chain Optimization, Materials Science, Quantum Computing, Networking and Chemistry
●
Signed Strategic Partnership with Carahsoft to Help Federal Agencies and Their Industry Partners Advance Quantum Adoption

SkyWater Foundry Services

●
Extended Quantum Manufacturing Collaboration with D-Wave Through Multi-Year Agreement to Support Its Dual-Platform Superconducting Roadmap
●
Won Multi-Year Commercial Foundry Contract with New Quantum Customer Qolab for SkyWater’s Newly Launched SC250 Superconducting Platform
●
Launched Industry’s First Quantum Manufacturing Platforms SC250 and SP90, and OnRamp Initiative to Bring Early-Stage Quantum Hardware Startups into the Foundry

“I am thrilled that we continued our growth trajectory in the third quarter, with revenue up 336% year-on-year. Major drivers included global deployments of our IonQ Tempo quantum computers, deliveries of our quantum sensing and space-based solutions, and closing on our acquisition of SkyWater, which had a very strong quarter of its own,” said Inder Singh, COO and CFO. “Our Remaining Performance Obligations more than doubled to $1.2 billion, even as we converted our backlog into record third quarter revenues. This was an especially strong quarter in quantum computing, which represented approximately two-thirds of new contract dollars signed by our IonQ Platform segment, driven by Superion 256 demand. We are pleased to raise our full-year 2026 revenue guidance to an industry record of more than half a billion dollars.”

Singh continued, “IonQ’s strong balance sheet, including $3.7 billion in cash and equivalents pro forma with our recent equity offering, gives us incredible financial firepower to continue investing in our technology, manufacturing infrastructure, and commercial capabilities as we scale the business and capitalize on the growing demand for quantum solutions.”

Third Quarter Financial Highlights

●
Recognized revenue of $173.8 million for the third quarter, which represents 336% year-on-year growth

●
Cash, cash equivalents, and investments were $1.7 billion as of September 30, 2026 and $3.7 billion pro-forma for the $2.0 billion equity offering that closed on October 16, 2026
●
Net income attributable to IonQ was $564.0 million and GAAP EPS was $1.42 for the third quarter, reflecting the non-cash mark-to-market impact of warrants
●
Adjusted EBITDA loss was ($133.6) million and Adjusted EPS was ($0.29) for the third quarter *

*Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures defined under “Non-GAAP Financial Measures,” below, and are reconciled to net income (loss) and GAAP EPS, the closest comparable GAAP measures, respectively, at the end of this release.

2026 Financial Guidance

●
For the full year 2026, IonQ is raising its revenue guidance to between $505 million and $515 million. For the full year, IonQ expects strong growth of 110% year-on-year in its quantum computing revenue

Third Quarter 2026 Conference Call

IonQ will host a conference call at 4:30 PM Eastern time today to discuss its results for the third quarter ended September 30, 2026 and to provide a business update. The call will be accessible by telephone at 1-888-349-0106 (domestic) or 1-412-902-0131 (international) with access code 7647193. The call will also be available live via webcast on the company’s website here, or directly here. A replay of the conference call will be available approximately three hours after its conclusion at 1-855-669-9658 (domestic) or 1-412-317-0088 (international) with access code 7647193 and will be available until 11:59 PM Eastern Time, November 19, 2026. An archive of the webcast will also be available here shortly after the call and will be available for one year.

Upcoming Q4 2026 Conference Participation

●
Cantor 2026 Crypto, FinTech, AI & Energy Infrastructure Conference taking place on Wednesday, November 11 in Miami
●
Reagan National Defense Forum (RNDF) taking place at the Ronald Reagan Presidential Library on Dec. 4-5 in Simi Valley, Calif.
●
Northland 2026 Growth Conference taking place virtually on Wednesday, December 16

Non-GAAP Financial Measures

To supplement IonQ’s condensed consolidated financial statements presented in accordance with GAAP, IonQ uses non-GAAP measures of certain components of financial performance. Adjusted EBITDA and Adjusted EPS are financial measures that are not required by or presented in accordance with GAAP. Management believes that these measures provide investors additional meaningful methods to evaluate certain aspects of the Company’s results period over period.

Adjusted EBITDA is defined as net income (loss) attributable to IonQ, Inc. before net income (loss) attributable to noncontrolling interests, interest income, interest expense, income tax (benefit) expense, depreciation and amortization, stock-based compensation, executive cash-based severance, changes in fair value from recurring fair value measurements (such as warrant liabilities, contingent consideration, and investments), offering costs associated with warrants, acquisition transaction and integration costs, and non-cash legal settlements and related costs. Adjusted EPS is defined as net income (loss) per share attributable to IonQ, or EPS, excluding the impact of stock-based compensation, executive cash-based severance, changes in fair value from recurring fair value measurements (such as of warrant liabilities, contingent consideration, and investments), offering costs associated with warrants, acquisition transaction and integration costs, and non-cash legal settlements and related costs. IonQ uses Adjusted EBITDA and Adjusted EPS to measure the operating performance of its business, excluding


specifically identified items that it does not believe directly reflect its core operations and that may not be indicative of recurring operations.

The presentation of these non-GAAP financial measures is not meant to be considered in isolation or as a substitute for the financial results prepared in accordance with GAAP, and IonQ’s non-GAAP measures may be different from non-GAAP measures used by other companies. IonQ shows a reconciliation of its non-GAAP measures to the most directly comparable GAAP measures at the end of this release.

Quantum Computing and Commercial Revenue

Quantum computing revenue includes sales of our quantum computing systems and hardware, related maintenance, training, and support, consulting services, including those related to applications development, and revenue from providing access to our quantum computers through quantum-computing-as-a-service (QCaaS). Commercial revenue includes all enterprise agreements with non-U.S. government customers, including agreements with leading universities.

Remaining Performance Obligations

Remaining performance obligations (RPOs) represent the total transaction price from signed contracts that has been allocated to performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. This includes both funded (firm orders for which funding has been authorized and appropriated) and unfunded (firm orders for which funding has not yet been appropriated) portions of the contract. Unexercised contract options are not included in remaining performance obligations until the time the option is exercised. We have conformed SkyWater’s RPO presentation with the existing IonQ policy. This policy incorporates all contracts, including those with expected durations of less than one year.

About IonQ

IonQ, Inc. [NYSE: IONQ] is the world’s leading full-stack quantum platform and foundry - delivering integrated quantum solutions across computing, networking, sensing, and security. IonQ’s newest generation of quantum computers, the Superion, is the latest in a line of cutting-edge systems. Earlier systems have helped customers and partners including Amazon Web Services and AstraZeneca achieve 20x performance results and accelerate innovation in drug discovery, materials science, financial modeling, logistics, cybersecurity, and defense. In 2025, the Company achieved 99.99% two-qubit gate fidelity, setting a world record in quantum computing performance.

Headquartered in College Park, Maryland, IonQ has operations across North America, Latin America, EMEA, and APAC. Our quantum computing services have been available through all major cloud providers since 2021, while we also meet the needs of networking and sensing customers across land, sea, air, and space. IonQ is making quantum platforms more accessible and impactful than ever before. Learn more at IonQ.com.

Note to Investors Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements contained in this press release other than statements of historical fact are forward-looking statements, including statements regarding our guidance and market consensus as to future results, our future product deliveries and contract performance, our OnRamp Foundry Initiative, future demand for our technologies, Elisity’s technological capabilities and leadership, the growing demand for quantum solutions and our ability to continue investing in our technology, manufacturing infrastructure and commercial capabilities and to scale the business. In some cases, you can identify these statements by forward-looking words such as “planned,” “accelerate,” “expect,” “believe,” “outlook,” “project,” “could,” “can,” “may,” “will,” “guidance,” “expectations,” and other similar expressions. These statements are only predictions based on our expectations and projections about future events as of the date of this press release and are subject to a number of risks, uncertainties and assumptions that may prove incorrect, any of which could cause actual results to differ materially from those expressed or implied by such statements, including, among others, those described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 filed with the Securities and Exchange


Commission. New risks emerge from time to time, and it is not possible for our management to predict all risks, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement we make. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. Except as otherwise required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

 


 

IonQ, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

(in thousands, except share and per share data)

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenue

 

$

173,831

 

 

$

39,866

 

 

$

318,549

 

 

$

68,126

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue (excluding depreciation and amortization)

 

 

135,804

 

 

 

21,253

 

 

 

245,168

 

 

 

33,895

 

Research and development

 

 

141,670

 

 

 

66,298

 

 

 

428,037

 

 

 

209,610

 

Sales and marketing

 

 

48,526

 

 

 

14,441

 

 

 

110,857

 

 

 

33,928

 

General and administrative

 

 

153,264

 

 

 

82,505

 

 

 

359,454

 

 

 

154,418

 

Depreciation and amortization

 

 

127,642

 

 

 

24,182

 

 

 

216,858

 

 

 

41,359

 

Total operating costs and expenses

 

 

606,906

 

 

 

208,679

 

 

 

1,360,374

 

 

 

473,210

 

Loss from operations

 

 

(433,075

)

 

 

(168,813

)

 

 

(1,041,825

)

 

 

(405,084

)

Gain (loss) on change in fair value of warrant liabilities

 

 

896,156

 

 

 

(881,847

)

 

 

304,669

 

 

 

(882,930

)

Interest income, net

 

 

19,844

 

 

 

14,437

 

 

 

80,057

 

 

 

26,469

 

Interest expense

 

 

(2,315

)

 

 

—

 

 

 

(2,315

)

 

 

—

 

Offering costs associated with warrants

 

 

—

 

 

 

(22,847

)

 

 

—

 

 

 

(22,847

)

Other income (expense), net

 

 

(59,198

)

 

 

(980

)

 

 

4,387

 

 

 

(697

)

Income (loss) before income tax benefit (expense)

 

 

421,412

 

 

 

(1,060,050

)

 

 

(655,027

)

 

 

(1,285,089

)

Income tax benefit (expense)

 

 

141,702

 

 

 

4,438

 

 

 

154,151

 

 

 

19,695

 

Net income (loss)

 

$

563,114

 

 

$

(1,055,612

)

 

$

(500,876

)

 

$

(1,265,394

)

Net income (loss) attributable to noncontrolling interests

 

 

(843

)

 

 

(657

)

 

 

(2,451

)

 

 

(1,349

)

Net income (loss) attributable to IonQ, Inc.

 

$

563,957

 

 

$

(1,054,955

)

 

$

(498,425

)

 

$

(1,264,045

)

Net income (loss) per share attributable to IonQ, Inc.
   Common stockholders

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

1.42

 

 

$

(3.58

)

 

$

(1.34

)

 

$

(4.89

)

Diluted

 

$

1.35

 

 

$

(3.58

)

 

$

(1.34

)

 

$

(4.89

)

Weighted average shares used in computing net income
   (loss) per share attributable to IonQ, Inc. common
   stockholders

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

388,585,082

 

 

 

294,524,786

 

 

 

371,798,334

 

 

 

258,324,714

 

Diluted

 

 

400,865,291

 

 

 

294,524,786

 

 

 

371,798,334

 

 

 

258,324,714

 

 

 


 

 

IonQ, Inc.

Condensed Consolidated Balance Sheets

(unaudited)

(in thousands)

 

 

September 30,

 

 

December 31,

 

 

2026

 

 

2025

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

209,454

 

 

$

1,030,865

 

Short-term investments

 

 

788,458

 

 

 

1,361,291

 

Accounts receivable, net

 

 

165,076

 

 

 

66,532

 

Contract assets, net

 

 

57,230

 

 

 

—

 

Prepaid expenses and other current assets

 

 

317,919

 

 

 

127,751

 

Total current assets

 

 

1,538,137

 

 

 

2,586,439

 

Long-term investments

 

 

664,482

 

 

 

944,643

 

Property and equipment, net

 

 

859,423

 

 

 

120,145

 

Intangible assets, net

 

 

1,145,061

 

 

 

767,432

 

Goodwill

 

 

3,222,103

 

 

 

1,963,584

 

Other noncurrent assets

 

 

423,746

 

 

 

188,115

 

Total Assets

 

$

7,852,952

 

 

$

6,570,358

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

69,581

 

 

$

26,138

 

Accrued expenses and other current liabilities

 

 

175,268

 

 

 

98,571

 

Current portion of long-term debt

 

 

8,849

 

 

 

—

 

Contract liabilities

 

 

109,291

 

 

 

42,116

 

Total current liabilities

 

 

362,989

 

 

 

166,825

 

Long-term debt, net of current portion

 

 

56,761

 

 

 

—

 

Contract liabilities, net of current portion

 

 

132,519

 

 

 

1,921

 

Warrant liabilities

 

 

2,124,224

 

 

 

2,471,577

 

Other noncurrent liabilities

 

 

152,020

 

 

 

116,343

 

Total liabilities

 

$

2,828,513

 

 

$

2,756,666

 

Stockholders’ Equity:

 

 

 

 

 

 

Common stock

 

$

41

 

 

$

36

 

Additional paid-in capital

 

 

6,750,217

 

 

 

5,006,250

 

Accumulated deficit

 

 

(1,692,523

)

 

 

(1,194,098

)

Accumulated other comprehensive income (loss)

 

 

(67,362

)

 

 

(12,671

)

Total IonQ, Inc. stockholders’ equity

 

$

4,990,373

 

 

$

3,799,517

 

Noncontrolling interests

 

 

34,066

 

 

 

14,175

 

Total stockholders’ equity

 

 

5,024,439

 

 

 

3,813,692

 

Total Liabilities and Stockholders’ Equity

 

$

7,852,952

 

 

$

6,570,358

 

 

 


 

 

IonQ, Inc.

Condensed Consolidated Statements of Cash Flows

(unaudited)

(in thousands)

 

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income (loss)

 

$

(500,876

)

 

$

(1,265,394

)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

216,858

 

 

 

41,359

 

Stock-based compensation

 

 

417,268

 

 

 

205,366

 

(Gain) loss on change in fair value of warrant liabilities

 

 

(304,669

)

 

 

882,930

 

Deferred income taxes

 

 

(154,797

)

 

 

(19,885

)

(Gain) loss on change in fair value of contingent consideration

 

 

(23,277

)

 

 

288

 

(Gain) loss on change in fair value of strategic investments

 

 

(5,597

)

 

 

(136

)

Other, net

 

 

10,783

 

 

 

(447

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(18,469

)

 

 

(15,849

)

Contract assets

 

 

(32,018

)

 

 

—

 

Prepaid expenses and other current assets

 

 

(141,537

)

 

 

(42,572

)

Accounts payable

 

 

6,114

 

 

 

(17,413

)

Accrued expenses and other current liabilities

 

 

(47,398

)

 

 

27,777

 

Contract liabilities

 

 

15,098

 

 

 

268

 

Other assets and liabilities

 

 

(7,801

)

 

 

(4,969

)

Net cash provided by (used in) operating activities

 

$

(570,318

)

 

$

(208,677

)

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property and equipment

 

 

(34,924

)

 

 

(7,628

)

Purchases of available-for-sale securities

 

 

(588,328

)

 

 

(1,252,367

)

Maturities of available-for-sale securities

 

 

1,099,900

 

 

 

407,730

 

Sales of available-for-sale securities

 

 

326,974

 

 

 

—

 

Purchases of strategic investments

 

 

(150,500

)

 

 

—

 

Businesses acquired, net of cash paid and acquired

 

 

(926,230

)

 

 

(13,100

)

Other investing, net

 

 

(3,962

)

 

 

(8,267

)

Net cash provided by (used in) investing activities

 

$

(277,070

)

 

$

(873,632

)

Cash flows from financing activities:

 

 

 

 

 

 

Proceeds from common stock and warrant issuance, net of issuance costs

 

 

—

 

 

 

1,358,254

 

Proceeds from stock options exercised

 

 

17,645

 

 

 

11,468

 

Proceeds from warrants exercised

 

 

8,707

 

 

 

6,708

 

Principal payments on long-term debt

 

 

(1,704

)

 

 

—

 

Other financing, net

 

 

3,693

 

 

 

986

 

Net cash provided by (used in) financing activities

 

$

28,341

 

 

$

1,377,416

 

Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash

 

 

(1,693

)

 

 

375

 

Net change in cash, cash equivalents and restricted cash

 

 

(820,740

)

 

 

295,482

 

Cash, cash equivalents and restricted cash at the beginning of the period

 

 

1,037,748

 

 

 

56,840

 

Cash, cash equivalents and restricted cash at the end of the period

 

$

217,008

 

 

$

352,322

 

 

 


 

 

IonQ, Inc.

Reconciliation of Non-GAAP Financial Measures

(unaudited)

(in thousands, except per share data)

 

Net Income (Loss) to Adjusted EBITDA

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net income (loss) attributable to IonQ, Inc.

 

$

563,957

 

 

$

(1,054,955

)

 

$

(498,425

)

 

$

(1,264,045

)

Net income (loss) attributable to noncontrolling interests

 

 

(843

)

 

 

(657

)

 

 

(2,451

)

 

 

(1,349

)

Interest income, net

 

 

(19,844

)

 

 

(14,437

)

 

 

(80,057

)

 

 

(26,469

)

Interest expense

 

 

2,315

 

 

 

—

 

 

 

2,315

 

 

 

—

 

Income tax (benefit) expense

 

 

(141,702

)

 

 

(4,438

)

 

 

(154,151

)

 

 

(19,695

)

Depreciation and amortization

 

 

127,642

 

 

 

24,182

 

 

 

216,858

 

 

 

41,359

 

Stock-based compensation

 

 

146,906

 

 

 

72,945

 

 

 

417,268

 

 

 

205,366

 

Executive cash-based severance

 

 

2,582

 

 

 

7,392

 

 

 

5,188

 

 

 

7,392

 

(Gain) loss on changes in fair value measurements

 

 

(857,178

)

 

 

881,847

 

 

 

(333,542

)

 

 

882,930

 

Offering costs associated with warrants

 

 

—

 

 

 

22,847

 

 

 

—

 

 

 

22,847

 

Acquisition transaction and integration costs

 

 

42,732

 

 

 

16,363

 

 

 

70,838

 

 

 

32,303

 

Non-cash legal settlements and related costs

 

 

(175

)

 

 

—

 

 

 

5,525

 

 

 

—

 

Adjusted EBITDA(1)

 

$

(133,608

)

 

$

(48,911

)

 

$

(350,634

)

 

$

(119,361

)

 

(1) During the three and nine months ended September 30, 2026, Adjusted EBITDA includes $23.7 million and $60.2 million, respectively, in research and development costs related to our commercial relationship with SkyWater.

 

Net Income (Loss) per Share to Adjusted EPS

 

 

Three Months Ended
September 30,

 

 

2026

 

 

2025

 

 

 

Amount

 

 

Per Share

 

 

Amount

 

 

Per Share

 

Net income (loss) per share attributable to IonQ, Inc.
   Common stockholders

 

 

 

 

$

1.42

 

 

 

 

 

$

(3.58

)

Stock-based compensation

 

$

146,906

 

 

 

0.38

 

 

$

72,945

 

 

 

0.25

 

Executive cash-based severance

 

 

2,582

 

 

 

0.01

 

 

 

7,392

 

 

 

0.03

 

(Gain) loss on changes in fair value measurements

 

 

(857,178

)

 

 

(2.21

)

 

 

881,847

 

 

 

2.99

 

Offering costs associated with warrants

 

 

—

 

 

 

—

 

 

 

22,847

 

 

 

0.08

 

Acquisition transaction and integration costs

 

 

42,732

 

 

 

0.11

 

 

 

16,363

 

 

 

0.06

 

Non-cash legal settlements and related costs

 

 

(175

)

 

 

—

 

 

 

—

 

 

 

—

 

Adjusted EPS

 

 

 

 

$

(0.29

)

 

 

 

 

$

(0.17

)

 

 

 

Nine Months Ended
September 30,

 

 

 

2026

 

 

2025

 

 

 

Amount

 

 

Per Share

 

 

Amount

 

 

Per Share

 

Net income (loss) per share attributable to IonQ, Inc.
   Common stockholders

 

 

 

 

$

(1.34

)

 

 

 

 

$

(4.89

)

Stock-based compensation

 

$

417,268

 

 

 

1.12

 

 

$

205,366

 

 

 

0.79

 

Executive cash-based severance

 

 

5,188

 

 

 

0.01

 

 

 

7,392

 

 

 

0.03

 

(Gain) loss on changes in fair value measurements

 

 

(333,542

)

 

 

(0.90

)

 

 

882,930

 

 

 

3.42

 

Offering costs associated with warrants

 

 

—

 

 

 

—

 

 

 

22,847

 

 

 

0.09

 

Acquisition transaction and integration costs

 

 

70,838

 

 

 

0.19

 

 

 

32,303

 

 

 

0.13

 

Non-cash legal settlements and related costs

 

 

5,525

 

 

 

0.01

 

 

 

—

 

 

 

—

 

Adjusted EPS

 

 

 

 

$

(0.91

)

 

 

 

 

$

(0.43

)

 

 


 

 

Contacts

IonQ Media Contact:

media@ionq.co

IonQ Investor Contact:

investors@ionq.co

 


img108693469_0.gif

 

Exhibit 99.2

 

IonQ Completes Acquisition of Elisity, Extending Quantum Security for Enterprises and Government

 

●
Acquisition brings together post-quantum cryptography, quantum key distribution, and Zero Trust security in a single platform
●
Expands Customer Opportunities through Elisity’s 100+ Established Enterprise Deployments and Trusted CISO Relationships
●
Elisity Will Continue to Serve Customers Under Its Current Leadership

College Park, Md. - Nov. 4, 2026 - IonQ (NYSE: IONQ), the world's leading full-stack quantum platform and foundry, today completed its acquisition of Elisity, Inc., a Zero Trust security company, in an all-stock transaction. The combination extends IonQ’s quantum security strategy, adding Zero Trust technology that complements IonQ's post-quantum cryptography (PQC) and quantum key distribution (QKD) capabilities. These combined enhancements are intended to protect customers today, and keep them protected as post-quantum standards evolve.

"With the acquisition complete, IonQ now brings together post-quantum cryptography, quantum key distribution, and Zero Trust security in a single platform for the organizations that depend on it most," said Niccolo de Masi, Chairman and Chief Executive Officer of IonQ. "Enterprise and government organizations will now be able to draw on one security architecture to contain attacks operating at machine speed today, and protect sensitive information against future quantum threats. I'm glad to welcome James and the Elisity team to IonQ."

Elisity helps customers discover connected assets, understand network risks and enforce identity-based Zero Trust policies across their environments. With those insights, customers can prioritize where to deploy IonQ’s PQC and QKD solutions as they protect data against “Harvest Now, Decrypt Later” attacks and prepare for the next era of quantum threats.

“Joining IonQ gives our team the resources and scale to serve customers with the same focus we’ve always had,” said James Winebrenner, Chief Executive Officer of Elisity. “Our global customers depend on us to protect their networks every day. Building on what we’ve learned across more than 100 deployments, we’ll extend the Elisity platform customers already use to help them prepare for post-quantum cryptography.”

Elisity's customers will continue to be supported by the same teams and platform they rely on today, and existing deployments and their identity policies will carry forward.

 


img108693469_0.gif

 

At closing, IonQ issued $1.15 billion of consideration in common stock under the terms of the merger agreement. The sellers may earn up to an additional $150 million in consideration based on Elisity’s performance against revenue milestones through January 2028.

About IonQ

IonQ, Inc. [NYSE: IONQ] is the world’s leading quantum platform and foundry - delivering integrated quantum solutions across computing, networking, sensing, and security. IonQ’s newest generation of quantum computers, the Superion, is the latest in a line of cutting-edge systems. Earlier systems have helped customers and partners including Amazon Web Services, AstraZeneca, and NVIDIA achieve a 20x performance increase over previous quantum solutions and accelerate innovation in drug discovery, materials science, financial modeling, logistics, cybersecurity, and defense. In 2025, the company achieved 99.99% two-qubit gate fidelity, setting a world record in quantum computing performance.

Headquartered in College Park, Maryland, IonQ has operations across North America, Latin America, EMEA, and APAC. Our quantum computing services have been available through all major cloud providers since 2021, while we also meet the needs of networking and sensing customers across land, sea, air, and space. IonQ is making quantum platforms more accessible and impactful than ever before. Learn more at IonQ.com.

About Elisity

Elisity helps enterprises advance Zero Trust security for users, devices, workloads, AI agents, and other non-human identities. Elisity IdentityGraph correlates identity, asset, and risk information from native and partner sources to inform access decisions. Elisity's software policy layer uses the network to enforce access rules independently of the underlying network technology. Founded in 2019, Elisity has a global employee footprint and a growing number of customers in the Fortune 500. Learn more at elisity.com.

Note to Investors Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements contained in this press release other than statements of historical fact are forward-looking statements, including statements regarding the expected benefits of the acquisition, the combined company's products, customers, and markets, and the integration of Elisity. In some cases, you can identify these statements by forward-looking words such as "anticipate," "expect," "intend," "plan," "believe," "will," "position," "ensure," "ongoing," and other similar expressions. These statements are only predictions based on current expectations and projections and are subject to risks, uncertainties, and assumptions that may prove incorrect, any of which could cause actual results to differ materially from those expressed or implied. These include, among others, the retention of customers, partners, and employees of Elisity, the integration of the acquired business, the realization of anticipated benefits, and those described under the heading "Risk Factors" in IonQ's Annual Report on Form 10-K for the year ended December 31, 2025, filed

 


img108693469_0.gif

 

with the Securities and Exchange Commission (SEC), and in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, filed with the SEC. New risks emerge from time to time, and it is not possible for management to predict all risks. Investors are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. Except as otherwise required by law, IonQ undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.

 

 

Contacts

IonQ Investor Contact:

investors@ionq.co

 

IonQ Media Contact:

media@ionq.co

 

Elisity Media Contact:

Danielle Ostrovsky, ostrovsky@hi-touchpr.com